Join Import & Export Telegram Group📈
💰Join Import & Export Facebook Group
The US has the largest pharmaceutical market in the world with a value of 339,694 million dollars followed by Japan with 94,025 million dollars and China with 86,774 million dollars. In Germany, the value of its pharmaceutical market is about 45,828 million dollars and in France, it is about 37,156 million dollars. In Brazil, the value of its pharmaceutical market is about 30,670 million dollars. In Italy, the value is about 27,930 million dollars. In the UK, it is about 24,513 million dollars while in Canada it is about 21,353 million dollars. In Spain, it is about 20,741 million dollars.
World’s Largest Pharmaceutical Exporters: Germany with 84.7 billion dollars, Switzerland with 71.7 billion dollars, the United States with 49.7 billion dollars, Belgium with 45.7 billion dollars, and Ireland with 40 billion dollars.
The World’s Largest Pharmaceutical Importers: the United States with 99.7 billion dollars, Germany with 53.7 billion dollars, Belgium with 36.7 billion dollars, the United Kingdom with 33.8 billion dollars, and Switzerland with 29.3 billion dollars.
World's Top Pharmaceutical Producing Countries
The Top Five countries in Europe for pharma production. All located in Western Europe, Switzerland punches well above its weight to take the top spot. This data is taken from the 2021 edition of the EFPIA’s comprehensive annual data review of the European pharma industry.
Switzerland: Despite boasting a population just one-tenth the size of neighbor Germany, Switzerland is by far Europe’s biggest pharma producer, with production values of upwards of 54.3 billion Euros in 2019.
Switzerland is particularly strong in next-generation biologics manufacturing. As UCB’s Head of Global Manufacturing, Engineering and Health, Safety & Environment Jacques Marbehant points out, Manufacturing out of Switzerland might cost slightly more than other countries but continues to serve us well because we can tap into unique knowledge and know-how while benefitting from the extremely high levels of production that you get out here. What’s more, the made-in Switzerland brand carries a special association with quality and precision, which is thoroughly pivotal in our niche. Multinationals doubling down on Swiss manufacturing and exports include MSD, whose R and D and manufacturing facility in Schachen plays a crucial role in manufacturing clinical supply for studies worldwide, and CDMO Lonza, which is continually expanding its Swiss facilities to meet soaring global demand.
France: France is Europe’s second-largest pharma production hub at 35.8 billion Euros for 2019. The COVID 19 pandemic has however seen calls for an even greater chunk of the manufacturing value chain to be relocated to France amid fears of overreliance on suppliers from India and China.
Big French pharma manufacturers include Sanofi, which moved to invest 679 million dollars in vaccine manufacturing in 2020, Servier, Ipsen, and Pierre Fabre.
Italy: Italy’s 34 billion Euros worth of pharmaceutical products in 2019 makes it Europe’s third-largest on that metric. Italian pharma’s manufacturing footprint is centered in Milan in the Lombardy region, home to 51 facilities, and Italy is the leading country in Europe In terms of the value of manufacturing produced by contract development and manufacturing organizations.
Germany: Home to innovative global giants such as Bayer, Boehringer Ingelheim, and Merck KGaA which has continuously made big manufacturing investments in recent years, Germany is Europe’s fourth-largest pharma producer, creating 33.2 billion Euros worth in 2019 according to the latest EFPIA figures.
As Germany Trade and Invest’s 2021 to 22 Pharma Industry Overview notes the country is the largest exporter of medicinal products and ranks among the top pharmaceutical producers worldwide. In light of the global need for personalized medicine, Germany has also evolved into one of the main suppliers of novel biopharmaceuticals.
UK: Rounding out the list is the United Kingdom, where pharma production value was valued at 23 billion Euros for 2019. Flagship British pharma manufacturers include AstraZeneca and GSK and the country is recognizing pharmaceutical production as increasingly important, as outlined in the ABPI’s 78 pages Manufacturing Vision for UK Pharma.
Which Countries Buy And Sell the Most Drugs?
The pharmaceutical industry is incredibly valuable and is continuing to grow. But just how much of the world’s imports and exports involve pharmaceuticals.
The United States is, by far, the world’s biggest importer of pharmaceuticals at 99.7 billion dollars, as the opioid crisis in the United States carries on, pharmaceutical companies are being scrutinized, as was demonstrated in the Johnson and Johnson settlement.
Despite the scrutiny, the pharmaceutical industry is continuing to grow at a rapid rate. Pharmaceutical companies are being forced to pay hefty fines for their role in the opioid epidemic.
We have pulled data from the World Trade Organization on pharmaceutical imports and exports throughout the world in 2018. Using this data, here are two models to portray the world’s largest exporters and importers of pharmaceuticals around the world. Each country’s pharmaceutical trade is represented by a pill. The larger the pill, the higher the value of exports or imports.
World’s Largest Pharmaceutical Exporters: Germany with 84.7 billion dollars, Switzerland with 71.7 billion dollars, the United States with 49.7 billion dollars, Belgium with 45.7 billion dollars, and Ireland with 40 billion dollars.
World’s Largest Pharmaceutical Importers: the United States with 99.7 billion dollars, Germany with 53.7 billion dollars, Belgium with 36.7 billion dollars, the United Kingdom with 33.8 billion dollars, and Switzerland with 29.3 billion dollars.
The pharmaceutical industry accounts for tens of billions of dollars in international trade each year, much of which comes from Europe and the United States. As the opioid crisis in the United States continues to rage on, it might not come as a surprise to see that the United States leads the world in pharmaceutical imports. While local and state governments are trying to hold Big Pharma responsible for its role in the opioid crisis, pharmaceutical companies aren’t concerned about U.S. drug regulations. Big Pharma is a massive industry and has plans to grow even more by targeting growing opioid markets in countries like India. Though many people around the world are concerned about the growing demand for pharmaceuticals, this demand is fueling the growth of these massive pharmaceutical companies. As such, the industry is likely to continue playing a major role in the global economy in the coming years. We all know the pharmaceutical industry has a major impact on the global economy. By analyzing available models, we can get an even better understanding of how Big Pharma affects countries around the world.
Global sales from worldwide exports of drugs and medicines in 2020 totaled 407.7 billion dollars.
Overall the value of drugs and medicines delivered via international markets increased by an average of 21 percent for all exporting countries since 2016 when drugs and medicines shipments were valued at 337 billion dollars. Year over year, there was a 6.9 percent gain from 2019 to 2020.
Among continents, European countries sold the highest dollar value worth of exported drugs and medicines during 2020 with shipments from Europe accumulating to 328.4 billion dollars or 80.5 percent of the global total. In second place were pharmaceutical exporters in Asia at 9.9 percent while 8.1 percent of worldwide drugs and medicine shipments originated from North America.
Smaller percentages came from suppliers of drugs and medicines in Latin America at 0.8 percent excluding Mexico but including the Caribbean, Oceania at 0.4 percent led by Australia and New Zealand, then Africa at 0.2 percent.
Here are the 15 countries that exported the highest dollar value worth of drugs and medicines during 2020.
Germany with 60.8 billion dollars equivalent to 14.9 percent of total exported drugs and medicines, Switzerland with 48.1 billion dollars equivalent to 11.8 percent, Belgium with 31.1 billion dollars equivalent to 7.6 percent, France with 28.4 billion equivalent to 7 percent, Italy with 27.2 billion dollars equivalent to 6.7 percent, The United States with 24.7 billion dollars equivalent to 6.1 percent, Ireland with 23.1 billion dollars equivalent to 5.7 percent, The Netherlands with 19.8 billion dollars equivalent to 4.9 percent, the United Kingdom with 18.7 billion dollars equivalent to 4.6 percent, India with 17 billion dollars equivalent to 4.2 percent, Denmark with 16.7 billion dollars equivalent to 4.1 percent, Spain with 10.9 billion dollars equivalent to 2.7 percent, Sweden with 8.9 billion equivalent to 2.2 percent, Canada with 7.6 billion dollars equivalent to 1.9 percent, and Slovenia with 7.3 billion dollars equivalent to 1.8 percent of global exportation.
By value, the listed 15 countries shipped 85.9 percent of all exported drugs and medicine for 2020.
Among the above countries, the fastest growing exporters of drugs and medicines from 2019 to 2020 were: Slovenia up by 42.2 percent, Ireland up by 28.8 percent, India up by 13.5 percent, and Italy up by 11.2 percent.
Those countries that posted the slowest gains year over year were: Switzerland up by 0.7 percent, Canada up by 1.6 percent, the United Kingdom up by 1.6 percent, the United States up by 1.8 percent, and Germany up by 6.5 percent.
The pharmaceutical industry discovers, develops, produces, and markets drugs or pharmaceutical drugs for use as medications to be administered to patients, to cure them, vaccinate them, or alleviate their symptoms. Pharmaceutical companies may deal in generic or brand medications and medical devices. They are subject to a variety of laws and regulations that govern the patenting, testing, safety, efficacy, and marketing of drugs. Hence when you hear the term pharmaceuticals it means drugs or medicines.
From native apothecaries producing drugs derived from botanicals to wholesale production of drugs today, pharmaceuticals have become a big global sector in the world economy. In short, the industry has been at the forefront of the discovery, development, production, and marketing of drugs. The pharmaceutical companies have also been involved in charitable causes that have allowed drug donations in developing countries where the need for their medications is great. Most of these causes are cancer, aids, malaria, tuberculosis, parasitic, and other tropical diseases. These drugs may be branded or generic.
The global pharmaceutical industry is an important aspect of the world economy today, providing about one trillion US dollars in revenues annually. The American pharmaceutical industry accounts for about 40 percent of these revenues. However, China is fast catching up as having the fastest growth in the industry. European pharmaceuticals have also shown high revenues in prescription sales.
Biggest Global Pharmaceutical Markets Companies:
In the US, Pfizer leads in sales revenues of about 45 billion dollars in 2013 while Johnson and Johnson realized revenue of 70,074 million dollars in 2015. In Switzerland, Novartis made 47,101 million dollars in revenues in 2014 while Roche realized 39,120 million dollars in the same year. In France, Sanofi made 36,437 million dollars in 2014 while in Japan, Takeda made 20,446 million dollars 2014. Bayer in Germany made 15,486 million dollars in 2014.
Monitoring The Pharmaceutical Industry:
Monitoring of the pharmaceutical industry involves several aspects such as environmental monitoring in drug production; decontamination; microbiological testing; storage; and wastewater management. These processes involve meeting regulatory rules for product safety and marketing. The issue of adverse drug effects has been the initiative behind strict regulations of the pharmaceutical industry worldwide. These complaints have reached 1000 or more cases a year for every key marketed drug product sold in the market in recent decades.
Pharmacovigilance has become important in the industry as well in monitoring unrecognized drug risks, recognizing predisposing factors, and refuting spurious safety claims of drugs. In recent decades, pharmaceutical companies themselves have established their monitoring units to further the safety of their products. Pharmacovigilance has its origins in clinical medicine, clinical and pre-clinical pharmacology, immunology, toxicology, and epidemiology. Physicians and other closely related sources are the usual information regarding adverse drug reactions.
Different methods of reporting ADRs are practiced in different nations which account for the actions taken by the pharmaceutical companies. In the US, patient reporting stands as the most source of ADRs while in the UK and Sweden, reports come from physicians through medical representatives.
The reporting of rare ADRs however, would take more examination. Many ADRs are published in medical journals, but disadvantages come as not many patients are readers of these publications. Every major country in the world today has their own national regulatory body and also several international organizations that investigate ADRs.
WATCH FULL VIDEO BELOW: TOP PHARMACEUTICAL MANUFACTURING COUNTRIES IN THE WORLD - TOP IMPORT & EXPORTING COUNTRIES
https://www.youtube.com/watch?v=6Ym4W48zAqA
If you are new to Big Man Business, please subscribe to our YouTube Channel for more business expert contents
Conclusion
The pharmaceutical industry accounts for tens of billions of dollars in international trade each year, much of which comes from Europe and the U.S. Pfizer leads in sales revenues of about 45 billion dollars in 2013 while Johnson and Johnson realized revenue of 70,074 million dollars in 2015.
Tags:
world pharmaceutical production
top pharmaceutical importing countries
u.s. pharmaceutical exports
pharmacy of the world
which country is the largest producer of medicines in the world 2022
💰Join Import & Export Facebook Group
Join Import & Export Telegram Group📈
Related Posts
None found